https://www.marketscreener.com/quote/stock/RAIN-ONCOLOGY-INC-121986263/news/Rain-Therapeutics-Announces-Completion-of-Enrollment-in-Phase-3-MANTRA-Trial-for-Milademetan-in-Lipo-41200379/?utm_source=telegram&utm_medium=social&utm_campaign=share